RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee’s recommendations.
More from New Å®ÉúСÊÓƵ
Explore the latest news, articles and features
Technology
Record-breaking IBM chip uses trick to cram in 100 billion transistors
News
Health
Bacteria-killing viruses redirect vaccine immunity to destroy cancer
News
Humans
Lost books by ancient philosophers recovered from 'unreadable' scrolls
News
Space
Possible signs of ancient life on Mars are rich in complex carbon
News
Popular articles
Trending New Å®ÉúСÊÓƵ articles
1
Woman with Alzheimer's starts conversing again after taking psilocybin
2
Possible signs of ancient life on Mars are rich in complex carbon
3
Our verdict on The Selfish Gene: An unpopular piece of popular science
4
The 17 best popular science books of 2026 so far
5
Faecal transplant makes the brains of old mice act young again
6
How some people's brains make an extraordinary recovery from stroke
7
How menopause radically changes the brain – and what happens after
8
Record-breaking IBM chip uses trick to cram in 100 billion transistors
9
The best sci-fi novel in 2026 so far – plus 6 other great reads
10
You should turn off fans when it's too hot – but how hot is too hot?
